Delivery Order SPE2DB22D2103-SPE2DB25FR8UW
Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $4.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,211.90 firm fixed-price delivery order is for ENGERIX-B 20 MCG/ML SYRNML, with a completion date of February 26, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- This federal contract award, valued at $3,182.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of ENGERIX-B 20 MCG/ML VIALML, a vaccine product. The contract has an ultimate completion date of January 9, 2025 and a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,656.60, is a Firm Fixed Price Delivery Order for the supply of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has a completion date of January 30, 2025 and was awarded on January 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,744.48, is a Firm Fixed Price Delivery Order for the medical product ENGERIX-B 20 MCG/ML SYRNML. The ultimate completion date is March 10, 2025. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,689.62 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has an ultimate completion date of September 16, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,342.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 3, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,893.22 firm fixed price delivery order is for ENGERIX-B 20 MCG/ML SYRNML, a type of vaccine product. The contract has a period of performance extending to June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,751.90 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 5, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $52,204.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the provision of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product, with a completion date of January 28, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML medical supplies to the Defense Logistics Agency (DLA). The $2,340.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...